Targeting cancer stem cells to suppress acquired chemotherapy resistance Journal Article


Authors: Vidal, S. J.; Rodriguez Bravo, V.; Galsky, M.; Cordon-Cardo, C.; Domingo-Domenech, J.
Article Title: Targeting cancer stem cells to suppress acquired chemotherapy resistance
Abstract: Acquired resistance has curtailed cancer survival since the dawn of the chemotherapy age more than half a century ago. Although the application of stem cell (SC) concepts to cancer captured the imagination of scientists for many years, only the last decade has yielded substantial evidence that cancer SCs (CSCs) contribute to chemotherapy resistance. Recent studies suggest that the functional and molecular properties of CSCs constitute therapeutic opportunities to improve the efficacy of chemotherapy. Here we review how these properties have stimulated combination strategies that suppress acquired resistance across a spectrum of malignancies. The clinical implementation of these strategies promises to rejuvenate the effort against an enduring challenge.
Keywords: review; antineoplastic agents; antineoplastic agent; neoplasm; neoplasms; animal; metabolism; animals; drug effect; drug resistance; pathology; drug resistance, neoplasm; neoplastic stem cells; cancer stem cell; neoplasms, experimental; experimental neoplasm; tumor microenvironment; humans; human
Journal Title: Oncogene
Volume: 33
Issue: 36
ISSN: 0950-9232
Publisher: Nature Publishing Group  
Date Published: 2014-09-04
Start Page: 4451
End Page: 4463
Language: English
PUBMED: 24096485
PROVIDER: scopus
DOI: 10.1038/onc.2013.411
DOI/URL:
Notes: Export Date: 1 December 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors